Earnings · Hong Kong stocks

CanSino Biologics, Inc. Class H (6185) earnings

CanSino Biologics, Inc. Class H published its quarterly report on 2026-10-27: net profit -36.40% year on year. The stock moved -6.32% in the 3 trading days after the report.

Report
quarterly report
Published
2026-10-27
Net profit YoY
-36.40%
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-1.53%—
3 days-6.32%—
7 days-1.38%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 2 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +1.24%).

PublishedEPS YoYEPSEPS surprise3 days after30 days after30d vs index
2026-10-27-36.40%0.07-72.20%-6.32%——
2026-08-27—0.16-21.97%-16.19%-0.51%+4.32%
2026-02-26—0.05-83.82%-3.86%+0.96%+2.39%
2025-10-27—0.11+2475.81%+6.34%-13.43%-8.17%
2025-04-29—-0.05-3396.50%+8.55%+20.23%+9.75%
2025-03-25—-0.63-326.37%+2.56%-4.21%-2.52%
2024-08-29—-0.22+40.77%+3.12%+37.73%+23.52%
2024-04-29—-0.69-111.71%+15.69%+20.48%+16.89%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: 6185

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.